Your browser doesn't support javascript.
loading
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.
Shapiro, Daniel D; Karam, Jose A; Master, Viraj A; Zemp, Logan W; Sexton, Wade J; Matin, Surena F; Spiess, Philippe E; Jason Abel, E.
Affiliation
  • Shapiro DD; Department of Urology, The University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. Electronic address: ddshapiro@wisc.edu.
  • Karam JA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Master VA; Department of Urology, Emory University Medical Center, Atlanta, GA, USA.
  • Zemp LW; Department of Urology, Moffitt Cancer Center, Tampa, FL, USA.
  • Sexton WJ; Department of Urology, Moffitt Cancer Center, Tampa, FL, USA.
  • Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Spiess PE; Department of Urology, Moffitt Cancer Center, Tampa, FL, USA.
  • Jason Abel E; Department of Urology, The University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Eur Urol ; 84(2): e55-e56, 2023 08.
Article in En | MEDLINE | ID: mdl-37149462
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Kidney Neoplasms Limits: Humans Language: En Journal: Eur Urol Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Kidney Neoplasms Limits: Humans Language: En Journal: Eur Urol Year: 2023 Document type: Article